U.S. Ophthalmic Compounding Pharmacies Market Growing Demand
U.S. Ophthalmic Compounding Pharmacies Market
Market Overview:
Ophthalmic compounding refers to the practice of
preparing customized eye medications. Compounded eye medications allows doctors
and patients more therapeutic options to treat specific eye conditions that are
not handled by commercially available products. Compounding pharmacists
formulate these custom medications by combining several ingredients together
based on a doctor's prescription. This allows medications to be tailored to an
individual's unique needs such as specific dosages, medication mixtures or
forms like gels or creams. The need for these personalized formulations is
increasing due to the rising prevalence of eye diseases and conditions that
require alternative treatment approaches. Compounded eye medications provide
improved outcomes for various eye conditions compared to commercially available
treatments.
Market key trends:
One of the major trends in the U.S. ophthalmic compounding pharmacies
market is the rising demand for customized medications. The number of patients
requiring personalized treatments is increasing due to growing eye health
issues. Compounded medications cater to those specific needs that are not met
by commercially available drugs. This has driven many pharmacists to offer
compounding services and develop expertise in formulating customized
treatments. Another key trend is the growing awareness among doctors and
patients regarding the benefits of tailored eye care therapies. Educational
initiatives by compounding pharmacies are increasing knowledge about
alternative treatment approaches which require skilled compounding. This has
boosted the adoption of compounded medications for addressing unique cases.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as the
compounded medications market requires expertise, specific licences and
certifications to prepare medication. However, the market is growing which
provides opportunities for new pharmacies.
Bargaining power of buyers: The bargaining power of buyers is moderate to high
as there are a large number of specialty and compounding pharmacies providing
similar customized medications. Buyers can negotiate on price and switch
between suppliers easily.
Bargaining power of suppliers: The bargaining power of suppliers is low as
compounding pharmacies require a variety of raw material suppliers. Suppliers
have minimal influence over pricing and other trade terms.
Threat of new substitutes: The threat of new substitutes is low as compounded
medications are customized to individual needs which cannot be easily
substituted by other treatment options or standardized drugs.
Competitive rivalry: High as the market is growing at a good pace attracting
many players resulting in high competition.
Key Takeaways
The U.S.
Ophthalmic Compounding Pharmacies Market Share is expected to witness
high growth, exhibiting a CAGR of 5% over the forecast period, owing to the
increasing prevalence of chronic eye diseases and growing geriatric population.
Regionally, the Western United States dominated the market and accounted for
over 30% of the overall market share in 2021 due to the presence of major
specialty pharmacy chains in states like California and growth in compounding
expertise. The South is projected to be the fastest growing region over the
forecast period.
Key players operating in the U.S. ophthalmic compounding pharmacies market are
Fagron Sterile Services US, New Drug Loft & VLS Pharmacy, Nora Apothecary,
Lifecare Pharmacy, Avella Specialty Pharmacy, Triangle Compounding Pharmacy,
O’Brien Pharmacy, Tache Pharmacy, Northmark Pharmacy, Edge Pharma, and
ImprimisRx. Fagron Sterile Services US led the market with over 15% revenue
share in 2021 owing to its strong expertise and experience in sterile
ophthalmic compounding.
Read
More:
https://www.dailyprbulletin.com/u-s-ophthalmic-compounding-pharmacies-market-trends/
Comments
Post a Comment